(Q44518141)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12870566%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Reboxetine promotes social bonding in healthy volunteers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12870566%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12870566%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Alyson J Bond

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12870566%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 June 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12870566%20AND%20SRC:MED&resulttype=core&format=json

Journal of Psychopharmacology

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12870566%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12870566%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12870566%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

189-195

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12870566%20AND%20SRC:MED&resulttype=core&format=json

Submissive behaviour and psychopathology.

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017002007

Clomipramine in adults with pervasive developmental disorders: a prospective open-label investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017002007

Depression and the response of others

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017002007

Review of the pharmacokinetics and metabolism of reboxetine, a selective noradrenaline reuptake inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017002007

Do noradrenaline and serotonin differentially affect social motivation and behaviour?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017002007

The two-period cross-over clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017002007

The effects of antidepressants on psychomotor function with particular reference to reboxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017002007

The effects of reboxetine and amitriptyline, with and without alcohol on cognitive function and psychomotor performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017002007

Selective alteration of personality and social behavior by serotonergic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017002007

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017002007

Comparison of the antidepressants reboxetine, fluvoxamine and amitriptyline upon spontaneous pupillary fluctuations in healthy human volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017002007

Effects of noradrenergic activity on temporal information processing in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017002007

The effects of reboxetine on autonomic and cognitive functions in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017002007

Disability and quality of life in social phobia: epidemiologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017002007

Difference in serotonergic and noradrenergic regulation of human social behaviours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017002007

Serotonergic intervention affects both social dominance and affiliative behaviour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017002007

Double-blind, placebo-controlled study with reboxetine in inpatients with severe major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017002007

Development and validation of brief measures of positive and negative affect: The PANAS scales

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017002007

Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017002007

10.1177/0269881103017002007

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12870566%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference